KCI to Be Acquired for $6.3 Billion

(KCI; San Antonio, TX, USA), a global medical technology company specializing in wound care, has signed a definitive merger agreement to be acquired by a consortium, in a transaction valued at US$6.3 billion. The consortium of investors includes Apax Partners (London, UK) together with controlled affiliates of Canada Pension Plan Investment Board (Toronto, Ontario, Canada) and the Public Sector Pension Investment Board (Ottowa, Ontario, Canada).

The agreement will pair KCI’s clinical expertise and global reach with a highly experienced group of healthcare investors. The consortium plans to partner with KCI's management to develop investments in the global medical products sector, enlarge the company's core business, and extend into new areas of opportunity.

“This consortium is a group of well-respected investors whose interest in KCI represents an endorsement of our market leadership, differentiated products and services and consistently strong performance,” said Cathy Burzik, KCI president and CEO. “We’re proud of what we’ve achieved in the marketplace and will continue making the right investments in people, product innovation and commercial capabilities that help the medical community deliver superior outcomes to patients.”

“We are highly impressed by the culture of innovation at KCI and are excited to work with a business that produces solutions that dramatically improve the lives of many people around the world,” said Buddy Gumina, partner and co-head of the Apax Healthcare team.

Related Links:
KCI
Apax Partners